All Stories

  1. Exploring the Speciation of trans -Aconitic Acid in Aqueous Solution: Interactions with Divalent Metal Cations of Environmental Relevance
  2. Investigation of the metal-binding site 2 of Y. pestis YfeA protein: solution studies of Fe( ii ), Mn( ii ...
  3. The comparison of metal-binding ability of the C-terminal region of Y. pestis, K. pneumoniae, and S. typhimurium FeoB protein
  4. The Coordination Chemistry of Two Peptidic Models of NFeoB and Core CFeoB Regions of FeoB Protein: Complexes of Fe(II), Mn(II), and Zn(II)
  5. Comparative analysis of metal-binding properties of C-terminal FeoB peptide models from selected Gram-negative bacteria
  6. Caffeic Acid Phenethyl Ester: A Potential Therapeutic Cancer Agent?
  7. Interplay of Metal Ions and Posttranslational Modifications in Proteins
  8. An Update on Glutathione's Biosynthesis, Metabolism, Functions, and Medicinal Purposes
  9. Iron-related Biomarkers in the Diagnosis and Management of Iron Disorders
  10. Coenzyme Q10 for Enhancing Physical Activity and Extending the Human Life Cycle
  11. Perspectives on Iron Deficiency as a Cause of Human Disease in Global Public Health
  12. Early-Life Lead Exposure: Risks and Neurotoxic Consequences
  13. Berberine: Pharmacological Features in Health, Disease and Aging
  14. Fe(II), Mn(II), and Zn(II) Binding to the C-Terminal Region of FeoB Protein: An Insight into the Coordination Chemistry and Specificity of the Escherichia coli Fe(II) Transporter
  15. A family of kojic acid derivatives aimed to remediation of Pb2+ and Cd2+
  16. Multifunctional role of zinc in human health
  17. Network-Based Prediction of Side Effects of Repurposed Antihypertensive Sartans against COVID-19 via Proteome and Drug-Target Interactomes
  18. Zn2+ and Cu2+ Interaction with the Recognition Interface of ACE2 for SARS-CoV-2 Spike Protein
  19. Zn<sup>2+</sup> and Cu<sup>2+</sup> Interaction with the Recognition Interface of ACE2 for SARS-CoV-2 Spike Protein
  20. Neurotransmitters Regulation and Food Intake: The Role of Dietary Sources in Neurotransmission
  21. Biological Effects of Human Exposure to Environmental Cadmium
  22. The Role of the Thioredoxin System in Brain Diseases
  23. Coenzyme Q10 in aging and disease
  24. The Role of Astaxanthin as a Nutraceutical in Health and Age-Related Conditions
  25. Natural Compounds and Products from an Anti-Aging Perspective
  26. Combined Supplementation of Coenzyme Q10 and Other Nutrients in Specific Medical Conditions
  27. Selenium: An Antioxidant with a Critical Role in Anti-Aging
  28. Polyphenols in Metabolic Diseases
  29. Quercetin in the Prevention and Treatment of Coronavirus Infections: A Focus on SARS-CoV-2
  30. Natural Dietary Compounds in the Treatment of Arsenic Toxicity
  31. Structural Identification of Metalloproteomes in Marine Diatoms, an Efficient Algae Model in Toxic Metals Bioremediation
  32. Thioredoxin reductase as a pharmacological target
  33. An updated overview on metal nanoparticles toxicity
  34. Gold nanoparticles and cancer: Detection, diagnosis and therapy
  35. Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach
  36. Metal Toxicity and Speciation: A Review
  37. Gold Clusters: From the Dispute on a Gold Chair to the Golden Future of Nanostructures
  38. Micronutrients deficiences in patients after bariatric surgery
  39. Individual risk management strategy for SARS-CoV-2 infection: A step toward personalized healthcare
  40. Analytical and in silico study of the inclusion complexes between tropane alkaloids atropine and scopolamine with cyclodextrins
  41. Awareness and risk factors of autism spectrum disorder in an Egyptian population
  42. A SARS-CoV-2 –human metalloproteome interaction map
  43. Phosphocalcic metabolism and the role of vitamin D, vitamin K2, and nattokinase supplementation
  44. The microbiota-mediated dietary and nutritional interventions for COVID-19
  45. Rh(I) Complexes in Catalysis: A Five-Year Trend
  46. Iron Deficiency in Obesity and after Bariatric Surgery
  47. Environmental barium: potential exposure and health-hazards
  48. The impact of glutathione metabolism in autism spectrum disorder
  49. The role of B vitamins in stroke prevention
  50. Krebs cycle: activators, inhibitors and their roles in the modulation of carcinogenesis
  51. Interrelations between COVID-19 and other disorders
  52. The Role of Diet and Supplementation of Natural Products in COVID-19 Prevention
  53. The glutathione system in Parkinson’s disease and its progression
  54. A Comprehensive Review on Oxysterols and Related Diseases
  55. The role of glutathione redox imbalance in autism spectrum disorder: A review
  56. Micronutrients as immunomodulatory tools for COVID-19 management
  57. Zinc Interactions with a Soluble Mutated Rat Amylin to Mimic Whole Human Amylin: An Experimental and Simulation Approach to Understand Stoichiometry, Speciation and Coordination of the Metal Complexes
  58. Biomarkers of senescence during aging as possible warnings to use preventive measures
  59. The Proteomics Study of Compounded HFE/TF/TfR2/HJV Genetic Variations in a Thai Family with Iron Overload, Chronic Anemia, and Motor Neuron Disorder
  60. Metals, autoimmunity, and neuroendocrinology: Is there a connection?
  61. Health benefits of xylitol
  62. Arsenic intoxication: general aspects and chelating agents
  63. Mercury-induced autoimmunity: Drifting from micro to macro concerns on autoimmune disorders
  64. Green and efficient configuration of integrated waste heat and cold energy recovery for marine natural gas/diesel dual-fuel engine
  65. Exploring the Specificity of Rationally Designed Peptides Reconstituted from the Cell-Free Extract of Deinococcus radiodurans toward Mn(II) and Cu(II)
  66. Interactions between iron and manganese in neurotoxicity
  67. The essential metals for humans: A brief overview
  68. Medical Uses of Silver: History, Myths, and Scientific Evidence
  69. A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays
  70. New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation
  71. Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+
  72. Mn(II) interaction with proteins responsible for ROS response and defense in DR
  73. Tungsten or Wolfram: Friend or Foe?
  74. The Intriguing Potential of “Minor” Noble Metals: Emerging Trends and New Applications
  75. Noble Metals in Pharmaceuticals: Applications and Limitations
  76. Looking at new ligands for chelation therapy
  77. A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies
  78. para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite
  79. Ni(II) interaction with a peptide model of the human TLR4 ectodomain
  80. Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1 H )-one, with Al(III), Cu(II) and Zn(II) ions
  81. Complex formation equilibria of Cu2+ and Zn2+ with Irbesartan and Losartan
  82. Toxicity of Nanoparticles: Etiology and Mechanisms
  83. Joint 16th International Symposium on Trace Elements in Man and Animals (TEMA-16), 12th Conference of the International Society for Trace Element Research in Humans (ISTERH 2017) and 13th Conference of the Nordic Trace Element Society (NTES 2017)
  84. Chemical features of in use and in progress chelators for iron overload
  85. Silver coordination compounds: A new horizon in medicine
  86. Manganese binding to antioxidant peptides involved in extreme radiation resistance in Deinococcus radiodurans
  87. Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents
  88. Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds
  89. Coordination Environment of Cu(II) Ions Bound to N-Terminal Peptide Fragments of Angiogenin Protein
  90. Substituent effects on ionization constants as a predictive tool of coordinating ability
  91. Immune compatible cystine-functionalized superparamagnetic iron oxide nanoparticles as vascular contrast agents in ultrasonography
  92. Manganism and Parkinson's disease: Mn(ii) and Zn(ii) interaction with a 30-amino acid fragment
  93. Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one
  94. Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators
  95. Tungsten-induced carcinogenesis in human bronchial epithelial cells
  96. An NMR study on the 6,6′-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with AlIII and ZnII ions
  97. Noble metals in medicine: Latest advances
  98. Kill or cure: Misuse of chelation therapy for human diseases
  99. A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity
  100. Nutritional Iron Deficiency: The Role of Oral Iron Supplementation
  101. Toxicity of Nanoparticles
  102. Ni(ii) binding to the 429–460 peptide fragment from human Toll like receptor (hTLR4): a crucial role for nickel-induced contact allergy?
  103. Interaction of Cu(II) and Ni(II) with Ypk9 Protein FragmentviaNMR Studies
  104. The Involvement of Amino Acid Side Chains in Shielding the Nickel Coordination Site: An NMR Study
  105. Nickel binding sites in histone proteins: Spectroscopic and structural characterization
  106. Front cover
  107. Interaction of divalent cations with peptide fragments from Parkinson's disease genes
  108. Manganese and cobalt binding in a multi-histidinic fragment
  109. Mn(ii) and Zn(ii) interactions with peptide fragments from Parkinson's disease genes
  110. NMR studies of zinc binding in a multi-histidinic peptide fragment
  111. Nickel binding to histone H4
  112. Metal-chelating properties of carvedilol: an antihypertensive drug with antioxidant activity
  113. Copper and nickel binding in multi-histidinic peptide fragments
  114. An NMR study on nickel binding sites in Cap43 protein fragments
  115. Copper(ii) binding to Cap43 protein fragments
  116. Paramagnetism-Based NMR Restraints Provide Maximum Allowed Probabilities for the Different Conformations of Partially Independent Protein Domains
  117. 4. Bioinspired Coordination Chemistry
  118. Multidimensional NMR spectroscopy for the study of histone H4–Ni(ii) interaction
  119. Nickel(II) binding to Cap43 protein fragments
  120. Experimentally exploring the conformational space sampled by domain reorientation in calmodulin
  121. The binding of Ni(ii) and Cu(ii) with the N-terminal tail of the histone H4